PEPTIDESMADE SIMPLE

Peptide Tier List

From Matthew Farrahi’s Peptide Insights research · Updated October 28, 2026

This is Matthew Farrahi's own ranking of the most common peptides, from his Peptide Insights video Ranking All 75 Peptides (S-F Tier List). He sorted each one by reward against risk and by how much research and history stand behind it, drawing on seven years of his own peptide research. It is his opinion, not a recommendation to use anything, and each library profile shows what the studies actually found.

For education and research only. Not medical advice, and not a recommendation to use anything.

S tier peptides

BPC-157
A large body of research, mostly in rats, and positive reports; his main con was water retention.
GHK-Cu
Wide use, plenty of research and many forms, including skin care.
Glutathione
A tripeptide the body makes, which he calls the master antioxidant, with lots of research behind it.
HCG (human chorionic gonadotropin)
A long record in fertility medicine; he feels more people should know about it.
HMG (human menopausal gonadotropin)
His top fertility pick, since it supplies both FSH and LH activity.
KPV
Anti-inflammatory research in the gut and skin, and rising popularity; his con was that it is newer.
NAD+
A coenzyme in every cell, not a peptide, with lots of research and positive reports.
Retatrutide
Its three-receptor design and the large average weight reductions in its trials; his con was that it is new.
Thymosin alpha-1
What he calls an all-around immune peptide, with long clinical use outside the US and many human trials, with mixed results.

A tier peptides

5-Amino-1MQ
A small molecule, not a peptide, rated for its NAD+ and metabolism effects in mice.
ARA-290 (cibinetide)
Nerve research that has reached small human trials; his con was its narrower focus.
Cagrilintide
Acts on appetite like GLP-1 drugs, but through amylin receptors; his con was that it is newer.
Dihexa
Reported in rat studies to support new connections between brain cells, though some people find it too much.
Gonadorelin
Prompts LH and FSH release in pulses for fertility; his cons were its short action and less research.
Human growth hormone (HGH)
A large body of research; his cons were its stigma and how often it is misused.
IGF-1 LR3
His top muscle-focused peptide, though it is potent and easy to misuse.
Ipamorelin
His top GHRP, which he values for a cleaner growth hormone pulse with less hunger, though mild.
LL-37
An immune and antimicrobial peptide the body makes, with small human wound trials so far, but potent, with side effects.
Melanotan I
His top tanning peptide, gentler and slower than Melanotan II.
MOTS-c
The most widely used mitochondrial peptide in his view, with positive reports.
Oxytocin
A well-researched hormone used in medicine, mainly in childbirth; he feels few people know about it.
Selank
His top anxiety-focused peptide, though not everyone notices it.
Semaglutide
Wide use and large trials, but he sees newer drugs in the class as stronger.
Semax
Brain performance research, held back by thinner research and mixed experiences.
TB-500
A widely used recovery peptide, though most of its research is on full-length thymosin beta-4.
Tesamorelin
His top GHRH analog, with large human trials behind it.
Testosterone
A steroid hormone, not a peptide, and one of the most studied; his cons were stigma, misuse and bad advice.
Tirzepatide
Wide use and large trials; like semaglutide, he placed it below retatrutide.

B tier peptides

CJC-1295 with DAC
Widely used and long acting, with more side effects when used incorrectly.
DSIP (delta sleep-inducing peptide)
The only sleep-focused peptide on his list, but results are hit or miss.
Epithalon (Epitalon)
A longevity bioregulator known for lab work on telomerase; experiences are hit or miss.
Follistatin 315
In his view one of the stronger muscle-focused peptides, as it binds myostatin; his con was more side effects.
Follistatin 344
In his view a stronger myostatin blocker than Follistatin 315, with the same side effect concern.
FOXO4-DRI
Studied in mice for clearing senescent cells, with few reported experiences.
Fragment 176-191
Rated above AOD-9604, but other peptides cover the same ground and more.
GHRP-2
A strong growth hormone releaser that also raises prolactin, with strong side effects.
GHRP-6
A strong growth hormone releaser that sharply raises hunger, which most people dislike.
Hexarelin
The most potent GHRP in his view, held back by side effects.
Humanin
A mitochondrial peptide of interest for longevity, with little research or use.
IGF-1 DES
More potent than IGF-1 in lab studies, but easy to misuse.
Kisspeptin-10
Acts at the top of the reproductive hormone system, but reported experiences are poor.
Melanotan II
Faster on skin color and affects sexual desire, but easier to misuse, with more side effects.
OS-01
Studied for senescent cells and used topically, but new, with little research.
PE-22-28
His top mood-focused peptide, fast acting in mouse studies, though the research is new.
PEG-MGF
Focused on muscle repair, but impractical to use.
Pinealon
A brain bioregulator he calls a strong spiritual peptide, with less research.
PNC-27
The first cancer-focused peptide he covers, studied mainly in lab work on cancer cells, and still new.
PT-141 (bremelanotide)
Acts on brain pathways of sexual desire, studied in women and men, with hit-or-miss experiences.
Sermorelin
A well-known GHRH analog with a long history, but its effect is mild.
SLU-PP-332
A small molecule, not a peptide, studied in mice as an exercise mimetic; new, with reported sleep problems.
SS-31 (elamipretide)
His top mitochondria-protecting peptide, though its effects are hard to feel.
Tesofensine
A small molecule, not a peptide, acting on brain chemistry and appetite, with less research.
VIP (vasoactive intestinal peptide)
Quickly widens blood vessels and relaxes smooth muscle, but is newer to most people.

C tier peptides

AOD-9604
Studied for fat metabolism, but reported experiences are poor, and a larger human trial showed little effect on weight.
B7-33
A relaxin-based peptide studied for fibrosis, with little research and a narrow focus.
Bronchogen
One of the few bioregulators aimed at the lungs, with less research and mixed experiences.
Cardiogen
One of the few bioregulators aimed at the heart, with less research and mixed experiences.
Cartalax
A bioregulator aimed at cartilage and joints, with less research and mixed experiences.
Cortagen
A bioregulator aimed at the nervous system, with less research and mixed experiences.
FGL(L)
Studied for new nerve cell growth, with little research behind it.
Livagen
A bioregulator aimed at the liver, with less research and mixed experiences.
Ovagen
A bioregulator aimed at ovarian tissue, with less research and mixed experiences.
P21
A milder brain-focused peptide with less research and a short history.
Pancragen
A bioregulator aimed at the pancreas, with less research and mixed experiences.
Prostamax
A bioregulator aimed at prostate tissue, with less research and mixed experiences.
Testagen
A bioregulator discussed for testosterone, with what he sees as a minor effect and less research.
Thymagen
A bioregulator aimed at the immune system, with less research and mixed experiences.
Thymalin
A bioregulator aimed at the thymus gland, with less research and mixed experiences.
Vesilute
A bioregulator aimed at the bladder and urethra, with less research and mixed experiences.

D tier peptides

Chonluten
An airway bioregulator he sees as too general, uncommon and little researched.
GHRH
Mirrors the body's own signal, but weak and rarely used.
MOD-GRF 1-29
Well researched and often paired with a GHRP, but weak on its own.
Vesugen
A broad blood vessel bioregulator with less research and mixed experiences.
Vilon
A general tissue bioregulator he sees as too broad, with less research.

F tier peptides

Matthew placed no peptides in F. The lowest tier he used in the video was D, for compounds he saw as weak on their own, too general or backed by little research. A low tier reflects his view of the research and experience behind a compound, not a finding that it is unsafe, and a high tier does not show that it works. Each library profile summarizes what the studies found.

Free for readers

The reader kit: lab math, a lab log and a COA checklist.

Printable sheets that go with the books, the free calculator, and an email when Matthew adds new pages.

Free. We'll send material on the peptides you've viewed here. Unsubscribe anytime. Privacy policy.

Questions

Which peptides are S tier?

In Matthew's ranking, the S tier is BPC-157, GHK-Cu, glutathione, HCG, HMG, KPV, NAD+, retatrutide and thymosin alpha-1.

How did Matthew rank the peptides?

He weighed reward against risk and looked at how much research and history stand behind each compound, along with what he has seen in seven years of researching peptides. The tiers are his opinion.

Are all of these peptides?

No. The list includes several compounds that are not peptides, such as NAD+, testosterone, HCG, HMG, 5-Amino-1MQ, SLU-PP-332 and tesofensine. HGH is a protein hormone.

Is a high tier a recommendation?

No. The tiers are Matthew's view, not medical advice. Many high-ranked compounds have mostly animal research, and each library profile explains what the studies found.

Want to go further than the books?

Peptide Academy is Matthew's community on Skool, free to join. Members ask Matthew live every Monday and get the full encyclopedias and courses, updated as the research changes.

  • A live Q&A with Matthew every Monday at 7 pm CT
  • Peptide, combo and reconstitution encyclopedias
  • Peptide Basics 101 and a lab course

Peptide Academy on Skool

Freeto join, no card

Members: $19 a month or $147 a year.

See what's inside
Free printable chartEvery common vial size, plus a lab log
Get it free